In the second of two Q&As with R&D colleagues, SAS' Udo Sglavo provides a window into how we approach drug-development challenges with machine learning.
In the second of two Q&As with R&D colleagues, SAS' Udo Sglavo provides a window into how we approach drug-development challenges with machine learning.
In our last article, Flower Power - Exploring Flower Essences, you learned about floral essences and how these liquid petal potions contain the bioenergetic imprint of the flower’s chi or life force. They work with the emotions of the body as noted by cultures throughout the centuries and can enhance
Before I started with SAS, I worked at the San Bernardino County Department of Behavioral Health. Among many other projects, our analytics work included integrating data from multiple county departments and risk stratifying citizens in the greatest need of public services. This led to our 1115 Whole Person Care (WPC) waiver